Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting cyclin-dependent kinases (CDKs). It shows potential in the development of anticancer agents due to its ability to modulate cell cycle progression. Also investigated for antiviral applications, especially in targeting viral replication mechanisms. Its structure allows for selective binding to ATP sites in enzymes, making it valuable in designing targeted therapies.